BlackRock Health Sciences Trust (BME) Stock Price, News & Analysis

Company Overview

BlackRock Health Sciences Trust (NYSE:BME) is a closed-end investment company focused on the global health sciences sector. The fund seeks to provide investors with total return through a combination of current income and capital appreciation by investing primarily in the equity securities of companies involved in health care and related industries.

Its portfolio may include companies engaged in pharmaceuticals, biotechnology, medical devices, health care services, diagnostics, and other areas supporting the development and delivery of health-related products and services. The trust can invest in businesses across the United States and international markets, giving shareholders exposure to a broad range of health sciences companies and geographies.

BlackRock Health Sciences Trust is managed by BlackRock Advisors, an affiliate of BlackRock, Inc. The fund has operated as a publicly traded closed-end fund since its inception in 2005. Like other closed-end funds, its shares trade on the New York Stock Exchange, while the portfolio is managed according to the trust’s stated investment objective and policies.

Key Stats

• Today's Range: $44.56 to $44.93
• 50-Day Range: $42.32 to $46.26
• 52-Week Range: $36.21 to $46.42
• Volume: 43,697 shs
• Average Volume: 44,530 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 7.03%
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Record date for 9/30 Dividend: 9/15/2026
• Ex-Dividend for 9/30 Dividend: 9/15/2026
• Today: 9/28/2026
• Dividend Payable: 9/30/2026
• Record date for 10/30 Dividend: 10/15/2026
• Ex-Dividend for 10/30 Dividend: 10/15/2026
• Dividend Payable: 10/30/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: Capital Markets
• Sub-Industry: Asset Management & Custody Banks
• Current Symbol: NYSE:BME
• CIK: 1314966
• Web: www.blackrock.com
• Phone: (800) 882-0052
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $104.37 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A